Novel antiviral material made from sugar developed by researchers
Modified sugar molecules have been developed by researchers as antiviral materials which are non-toxic to humans, according to a new study.
List view / Grid view
Modified sugar molecules have been developed by researchers as antiviral materials which are non-toxic to humans, according to a new study.
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...
The collaboration focuses on the delivery of an educational programme consisting of a suite of flexible Master’s level professional courses including short ones and a full Master’s programme.
Drug developers sometimes think of imaging as an emerging discipline. But John Waterton, Paul Hockings, Juliana Maynard and Caleb Roberts explain how imaging biomarkers are transforming drug development. Francesco Gatto and Jens Nielsen, from the Chalmers University of Technology in Sweden, discuss moving towards systems biomarkers for cancer diagnosis...
Drug developers sometimes think of imaging as an emerging discipline, full of esoteric technologies of marginal relevance to real-world clinical drug development. In fact, the opposite is true: imaging measurements (imaging biomarkers) are used daily in drug development and in personalised medicine. They assess target engagement and receptor occupancy in…
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The University of Manchester, Imperial College London, the University of Leeds, and University of Glasgow have all been included in the research grant...
11 August 2016 | By University of Manchester
Transgenic mice that develop symptoms of Alzheimer's disease were used with one group of 10 treated with mefenamic acid, and 10 with a placebo. The mice were treated at a time when they had developed memory problems. After one month's treatment, memory loss was completely reversed back to the levels…
9 May 2016 | By Victoria White, Digital Content Producer
Researchers from the University of Manchester have devised a method to selectively deliver drugs to a pregnant woman’s placenta without harming the foetus...
23 March 2016 | By Victoria White
Researchers have identified mutations in NSCLC that are key to tumour growth, offering a new way to differentiate patients with the disease...